Skip to content
APRAPRAPR757575

Drawing based on the label description. No photo yet.

“OTEZLA XR is available as 75 mg round, biconvex, pink, film-coated extended-release tablets with "APR 75" printed in black on one side and a hole or indentation on either side of the tablet, which may or may not be visible”

APR 75 pill

Pill with imprint APR 75 is pink, round, 12 mm and has been identified as Apremilast 75 mg. It is used for psoriatic arthritis. It is supplied by Amgen, Inc.

Apremilast 75 mg

Imprint
APR 75
Strength
75 mg
Used for
Psoriatic arthritis
Color
Pink
Shape
Round
Size
12 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Amgen, Inc
Drug class
Phosphodiesterase 4 inhibitor
NDC
55513-519, 55513-519-30, 55513-516, 55513-516-41, 55513-517, 55513-517-04, 55513-523, 55513-523-04, 55513-521, 55513-521-19, 55513-522, 55513-522-14

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Apremilast pills and guides

What is Apremilast used for?

Apremilast is used for psoriatic arthritis.

Medicine type
Phosphodiesterase 4 inhibitor
Official uses from the US prescribing label

Psoriatic Arthritis

OTEZLA is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with active psoriatic arthritis.

OTEZLA XR is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 50 kg with active psoriatic arthritis.

Plaque Psoriasis

OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.

OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

OTEZLA XR is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 50 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Oral Ulcers Associated with Behçet's Disease

OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with oral ulcers associated with Behçet's Disease.

From the FDA-approved label on DailyMed (published Sep 11, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows APR 75 and the other side has no imprint.
  • It is pink, round, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Otezla.

Ingredients

Active: Apremilast

Inactive: Hypromellose Acetate Succinate, Unspecified, Mannitol, Magnesium Stearate, Silicon Dioxide, Microcrystalline Cellulose, Sodium Chloride, Ferric Oxide Red, Cellulose Acetate, Polyethylene Glycol, Unspecified, Hypromellose, Unspecified, Titanium Dioxide, Ferrosoferric Oxide, Propranolol Glycol

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Apremilast pills